Skip to main content

Defibulation (Deinfibulation) for Type III FGM/C

Defibulation (deinfibulation) opens the infibulated scar in Type III FGM/C, exposing the urethral meatus and vaginal introitus. It can address obstruction, facilitate examination or intercourse, and enable vaginal birth, but it does not replace tissue removed by FGM/C. WHO's 2025 recommendation is conditional, based on low-certainty evidence, with informed decision-making and access to trained care.[8]

For the disease context, see Female Genital Mutilation / Cutting (FGM/C); for other reconstructive approaches, see the Vulvar Reconstruction database.

Indications​

WHO recommends offering deinfibulation to women and girls with Type III FGM, while noting limited direct evidence outside pregnant populations and no pediatric benefit studies. Symptoms and goals to explore during assessment include:[8]

  • Menstrual obstruction — prolonged, painful, foul-smelling menstruation behind the neo-introitus; rarely hematocolpos / hematometra
  • Dysmenorrhea from menstrual retention
  • Dyspareunia / apareunia in sexually active patients
  • Recurrent UTI and urinary obstruction
  • Scar pain or a suspected neuroma — assess separately; opening the infibulation alone may not address the cause
  • Pregnancy — to facilitate safe vaginal delivery and reduce obstetric complications[2]
  • Gynecologic-exam access and pre-conception preparation

Timing​

ContextPlanning considerations
Before pregnancyAn elective discussion may address urinary, menstrual, sexual or examination concerns and the person's preference.
AntepartumAllows counseling, healing and adjustment before birth; consider access to trained clinicians and the woman's wishes.
IntrapartumAn accepted alternative when opening is needed to facilitate vaginal birth; plan assessment, analgesia and availability of a trained clinician.
After delivery or outside pregnancyReassess remaining needs and the person's wishes rather than treating a missed earlier opportunity as a contraindication.

WHO states that either antepartum or intrapartum deinfibulation can be considered to facilitate vaginal birth; the timing recommendation is conditional on very-low-certainty evidence. There is no universal preferred trimester, 34-week cutoff or labor-stage rule. Qualitative research describes differing preferences and service barriers, so timing should be agreed through informed discussion.[4][8]

Anesthesia and preparation​

Local, regional and general anesthesia have been described. Choice depends on the extent of scarring, age, obstetric setting, anticipated discomfort, prior trauma, patient preference and available anesthesia expertise. Discuss the examination and procedure beforehand; local anesthesia should neither be mandatory nor categorically rejected for every adult.[1][3]

Offer an interpreter, chaperone and support person according to the patient's wishes. Ask about concerns around pain, memories of the original cutting, body image and the appearance after opening. For children or adolescents, involve appropriate pediatric, safeguarding and consent expertise.[1][4]

Operative description​

The core maneuver is division of the midline scar followed by suturing the divided edges to keep the introitus open. The following sequence summarizes published operative descriptions; the extent of opening depends on the actual anatomy.[3][8]

  1. With suitable positioning, exposure and anesthesia, identify the inferior opening and assess the location of the urethral meatus and underlying structures.
  2. Midline scar division. Open the fused scar progressively while protecting the urethra and any residual clitoral tissue; define these structures before extending the incision.
  3. The cut edges are everted and oversewn with fine absorbable suture, creating two labial-like edges and a patent introitus.
  4. Confirm the intended urethral and vaginal access, hemostasis and separation of the released edges.
  5. Send any excised tissue for histopathology if clinically indicated.

Day-case care is often feasible outside pregnancy; discharge and follow-up depend on the procedure, anesthesia and clinical circumstances.

Obstetric and Functional Outcomes​

Okusanya 2026 meta-analysis (8 studies, 3,166 women)​

The review included eight studies and 3,166 participants overall; the endpoints below draw on much smaller observational subsets with serious risk of bias and very-low-certainty evidence. The cesarean estimate is from one study, not a pooled eight-study result. These are associations, not guaranteed individual benefits:[2]

OutcomeEffect (vs non-deinfibulated Type III)
Emergency cesarean deliveryOR 0.16 (95% CI 0.06–0.42); one study, n = 250 (45/230 vs 12/20), with an especially small non-deinfibulated comparison group
Genital-tract lacerationsOR 0.48 (95% CI 0.29–0.79); three studies, n = 1,067
Antepartum vs intrapartum defibulationLimited observational comparisons do not establish a single preferred time; use the current WHO recommendation above

The same review did not establish reductions in postpartum hemorrhage, episiotomy, prolonged second stage or neonatal resuscitation, and found no eligible comparative studies for gynecologic, urologic or sexual-health outcomes. The nonobstetric indications above rest on anatomy, WHO guidance and separate clinical reports, not on this meta-analysis.[2][8]

Patient satisfaction​

  • Berg 2017 reviewed experiences with different FGM/C surgical interventions; reported satisfaction varied substantially. These mixed-procedure findings should not be presented as a deinfibulation-specific success rate.[5]
  • Nour's single-center Type III series included 40 operated women, 32 reached by telephone; among respondents, 94% would highly recommend deinfibulation and all reported satisfaction with results and appearance. This selected respondent sample is not a generalizable success rate.[9]
  • A minority experience distress related to the new genital appearance, and medicalized defibulation has limited social acceptance in some communities.[5][6]

Complications​

Discuss bleeding/hematoma, infection, pain, urinary difficulty, wound separation or re-adhesion, and the possible psychological response to anatomic change. Frequency varies by setting and the available studies do not justify a universal low-risk guarantee:

  • Hematoma, transient urinary retention, wound dehiscence.
  • Psychological response to anatomic change — multidisciplinary support recommended.

Re-infibulation prohibition​

A patient or family may request re-closure of the vulva after defibulation or after delivery. WHO considers reinfibulation a form of FGM medicalization and states that it should not be performed. Discuss this before the procedure and offer appropriate counseling and support.[8]

Counseling and Psychosocial Considerations​

Defibulation decisions are rarely single-visit:[1][4][6]

  • Multiple visits are commonly required to address fears, particularly loss-of-virginity concerns in unmarried patients.
  • Cultural barriers: qualitative work in Somali and Sudanese migrant populations identifies male-perceived loss of virility and pleasure as a specific deterrent to medicalized defibulation — such concerns can be discussed, but partners or family participate only at the woman's request. Their agreement is not a prerequisite.[6][8]
  • Mental-health integration: PTSD, depression, and somatization are common in this population and mental-health service provision remains globally deficient.[4]
  • Adolescent autonomy: legal and ethical complexity arises when an adolescent seeks defibulation but fears parental refusal or stigma — local statutes and best-interest standards apply.[1]
  • Trauma-informed care throughout — survivor-chosen support person, gender-of-provider preference, language-concordant interpreter where needed.

Positioning vs Reconstructive Procedures​

Defibulation opens the infibulation but does not restore tissue lost in Types I / II / III. Additional reconstruction is a separate, preference-sensitive discussion; the approaches below have differing and often limited evidence. They are not routine additions to deinfibulation.[7]

GoalProcedureCross-link
Open Type III introital fusionDefibulation (this page)—
Restore the glans clitoridis from scarFoldès reconstructionFoldès
Restore labia minora / vestibuleaOAP flap ± OD preputial flapaOAP
Alternative non-Foldès clitoral coverageMañero vaginal-mucosal graftMañero
Vulvar scarring / dyspareuniaFGM/C fat graftingFGM/C Fat Grafting

See Also​

References​

1. Young J, Nour NM, Macauley RC, Narang SK, Johnson-Agbakwu C. Diagnosis, management, and treatment of female genital mutilation or cutting in girls. Pediatrics. 2020;146(2):e20201012. doi:10.1542/peds.2020-1012

2. Okusanya B, Esu E, Nwachuku N, et al. Deinfibulation for improving obstetric, neonatal, gynecologic, and sexual-health outcomes in women and girls with Type III female genital mutilation: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2026;172(Suppl 1):31–47. doi:10.1002/ijgo.70759

3. Anand M, Stanhope TJ, Occhino JA. Female genital mutilation reversal: a general approach. Int Urogynecol J. 2014;25(7):985–986. doi:10.1007/s00192-013-2299-0

4. Jones L, Danks E, Costello B, et al. Views of female genital mutilation survivors, men and health-care professionals on timing of deinfibulation surgery and NHS service provision: qualitative FGM Sister study. Health Technol Assess. 2023;27(3):1–113. doi:10.3310/JHWE4771

5. Berg RC, Taraldsen S, Said MA, Sørbye IK, Vangen S. Reasons for and experiences with surgical interventions for female genital mutilation/cutting (FGM/C): a systematic review. J Sex Med. 2017;14(8):977–990. doi:10.1016/j.jsxm.2017.05.016

6. Johansen RE. Virility, pleasure and female genital mutilation/cutting: a qualitative study of perceptions and experiences of medicalized defibulation among Somali and Sudanese migrants in Norway. Reprod Health. 2017;14(1):25. doi:10.1186/s12978-017-0287-4

7. Chappell AG, Sood R, Hu A, et al. Surgical management of female genital mutilation-related morbidity: a scoping review. J Plast Reconstr Aesthet Surg. 2021;74(10):2467–2478. doi:10.1016/j.bjps.2021.05.022

8. World Health Organization. WHO guideline on the prevention of female genital mutilation and clinical management of complications. 2025. Deinfibulation recommendations and counseling.

9. Nour NM, Michels KB, Bryant AE. Defibulation to treat female genital cutting: effect on symptoms and sexual function. Obstet Gynecol. 2006;108(1):55–60. doi:10.1097/01.AOG.0000224613.72892.77